• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Retrospective Analysis of the Effects of Time on Compliance and Driving Pressures in ARDS.回顾性分析时间对 ARDS 患者顺应性和驱动压的影响。
Respir Care. 2023 Jan;68(1):52-59. doi: 10.4187/respcare.10080. Epub 2022 Jun 15.
2
Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.在高流量氧疗或无创通气期间急性呼吸窘迫综合征标准的局限性:来自危重症 COVID-19 患者的证据。
Crit Care. 2022 Mar 7;26(1):55. doi: 10.1186/s13054-022-03933-1.
3
The Use of High-Flow Nasal Cannula and Non-Invasive Mechanical Ventilation in the Management of COVID-19 Patients: A Prospective Study.高流量鼻导管和无创机械通气在 COVID-19 患者管理中的应用:一项前瞻性研究。
Viruses. 2023 Sep 5;15(9):1879. doi: 10.3390/v15091879.
4
Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study.高流量鼻导管给氧与无创通气序贯应用于急性呼吸衰竭的观察性初步研究。
Respir Care. 2015 Feb;60(2):170-8. doi: 10.4187/respcare.03075. Epub 2014 Oct 7.
5
[Effect of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy on the clinical efficacy of coronavirus disease 2019 patients with acute respiratory distress syndrome].无创正压通气和高流量鼻导管氧疗对2019冠状病毒病急性呼吸窘迫综合征患者临床疗效的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jun;33(6):708-713. doi: 10.3760/cma.j.cn121430-20210104-00002.
6
Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes.COVID-19 所致急性低氧性呼吸衰竭患者的无创通气和高流量鼻导管吸氧:一项回顾性研究其可行性、安全性和结局。
Respir Physiol Neurobiol. 2022 Apr;298:103842. doi: 10.1016/j.resp.2022.103842. Epub 2022 Jan 10.
7
Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study.高流量鼻导管给氧疗法在急性呼吸窘迫综合征患者中的应用:一项为期1年的观察性研究。
Respir Care. 2015 Feb;60(2):162-9. doi: 10.4187/respcare.03423. Epub 2014 Nov 4.
8
Comparison between high-flow nasal cannula and noninvasive ventilation in COVID-19 patients: a systematic review and meta-analysis.高流量鼻导管与无创通气在 COVID-19 患者中的比较:系统评价和荟萃分析。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221113663. doi: 10.1177/17534666221113663.
9
Comparison of High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure Due to Severe COVID-19 Pneumonia.比较高流量鼻导管和无创通气在严重 COVID-19 肺炎引起的急性低氧性呼吸衰竭中的应用。
Respir Care. 2021 Dec;66(12):1824-1830. doi: 10.4187/respcare.09130. Epub 2021 Sep 28.
10
Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial.经鼻高流量湿化氧疗联合无创通气预氧合在 ICU 低氧血症患者中插管:单中心、盲法、随机对照 OPTINIV 试验。
Intensive Care Med. 2016 Dec;42(12):1877-1887. doi: 10.1007/s00134-016-4588-9. Epub 2016 Oct 11.

本文引用的文献

1
Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units.1260 例 COVID-19 危重症患者入住 24 家意大利重症监护病房的与死亡率相关的危险因素的时间进程。
Intensive Care Med. 2021 Sep;47(9):995-1008. doi: 10.1007/s00134-021-06495-y. Epub 2021 Aug 9.
2
Static compliance and driving pressure are associated with ICU mortality in intubated COVID-19 ARDS.静态顺应性和驱动压与插管的新型冠状病毒肺炎急性呼吸窘迫综合征患者在重症监护病房的死亡率相关。
Crit Care. 2021 Jul 28;25(1):263. doi: 10.1186/s13054-021-03667-6.
3
The effect of driving pressures in COVID-19 ARDS: Lower may still be better as in classic ARDS.COVID-19 导致的急性呼吸窘迫综合征中的驱动压的影响:与经典 ARDS 一样,较低可能仍然更好。
Respir Investig. 2021 Sep;59(5):628-634. doi: 10.1016/j.resinv.2021.06.002. Epub 2021 Jul 6.
4
An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients.对机械通气的新冠患者呼吸系统顺应性的评估。
Crit Care. 2021 Jun 9;25(1):199. doi: 10.1186/s13054-021-03518-4.
5
Coronavirus Disease 2019 ICU Patients Have Higher-Than-Expected Acute Physiology and Chronic Health Evaluation-Adjusted Mortality and Length of Stay Than Viral Pneumonia ICU Patients.COVID-19 重症监护病房患者的急性生理学与慢性健康状况评估调整死亡率和住院时间高于病毒性肺炎重症监护病房患者。
Crit Care Med. 2021 Jul 1;49(7):e701-e706. doi: 10.1097/CCM.0000000000005012.
6
Twenty articles that critical care clinicians should read about COVID-19.重症监护临床医生应阅读的20篇关于新冠病毒病的文章。
Intensive Care Med. 2021 Mar;47(3):337-341. doi: 10.1007/s00134-020-06329-3. Epub 2021 Jan 3.
7
Silent or 'Happy' Hypoxemia: An Urgent Dilemma for COVID-19 Patient Care.静默性或“快乐”低氧血症:COVID-19 患者护理的紧迫难题。
MEDICC Rev. 2020 Oct;22(4):85-86. doi: 10.37757/MR2020.V22.N4.9.
8
Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study.COVID-19 和典型 ARDS 的生理学和定量 CT 扫描特征:一项匹配队列研究。
Intensive Care Med. 2020 Dec;46(12):2187-2196. doi: 10.1007/s00134-020-06281-2. Epub 2020 Oct 21.
9
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.COVID-19 相关性急性呼吸窘迫综合征的病理生理学:一项多中心前瞻性观察研究。
Lancet Respir Med. 2020 Dec;8(12):1201-1208. doi: 10.1016/S2213-2600(20)30370-2. Epub 2020 Aug 27.
10
Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic.COVID-19 大流行前早期急性呼吸窘迫综合征的顺应性表型。
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1244-1252. doi: 10.1164/rccm.202005-2046OC.

回顾性分析时间对 ARDS 患者顺应性和驱动压的影响。

A Retrospective Analysis of the Effects of Time on Compliance and Driving Pressures in ARDS.

机构信息

Creighton University School of Medicine, Division of Pulmonary and Critical Care, Omaha, Nebraska.

Creighton University School of Medicine, Department of Clinical Research, Omaha, Nebraska.

出版信息

Respir Care. 2023 Jan;68(1):52-59. doi: 10.4187/respcare.10080. Epub 2022 Jun 15.

DOI:10.4187/respcare.10080
PMID:35705249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9993514/
Abstract

BACKGROUND

The evolution of compliance and driving pressure in ARDS and the effects of time spent on noninvasive respiratory support prior to intubation have not been well studied. We conducted this study to assess the effect of the duration of noninvasive respiratory support prior to intubation (ie, noninvasive ventilation [NIV], high-flow nasal cannula [HFNC], or a combination of NIV and HFNC) on static compliance and driving pressure and retrospectively describe its trajectory over time for COVID-19 and non-COVID-19 ARDS while on mechanical ventilation.

METHODS

This is a retrospective analysis of prospectively collected data from one university-affiliated academic medical center, one rural magnet hospital, and 3 suburban community facilities. A total of 589 subjects were included: 55 COVID-19 positive, 137 culture positive, and 397 culture-negative subjects. Static compliance and driving pressure were calculated at each 8-h subject-ventilator assessment.

RESULTS

Days of pre-intubation noninvasive respiratory support were associated with worse compliance and driving pressure but did not moderate any trajectory. COVID-19-positive subjects showed non-statistically significant worsening compliance by 0.08 units per subject-ventilator assessment ( = .24), whereas COVID-19-negative subjects who were either culture positive or negative showed statistically significant improvement (0.12 and 0.18, respectively; both < .05); a statistically similar but inverse pattern was observed for driving pressure.

CONCLUSIONS

In contrast to non-COVID-19 ARDS, COVID-19 ARDS was associated with a more ominous trajectory with no improvement in static compliance or driving pressures. Though there was no association between days of pre-intubation noninvasive respiratory support and mortality, its use was associated with worse overall compliance and driving pressure.

摘要

背景

ARDS 患者顺应性和驱动压的演变以及插管前接受无创性呼吸支持的时间长短的影响尚未得到很好的研究。我们进行这项研究是为了评估插管前无创性呼吸支持(即无创通气[NIV]、高流量鼻导管[HFNC]或两者联合)的持续时间对静态顺应性和驱动压的影响,并回顾性描述 COVID-19 和非 COVID-19 ARDS 患者在机械通气时其随时间的变化轨迹。

方法

这是对一家大学附属学术医疗中心、一家农村磁铁医院和 3 家郊区社区设施前瞻性收集数据的回顾性分析。共纳入 589 例患者:55 例 COVID-19 阳性、137 例培养阳性和 397 例培养阴性。在每次 8 小时的受试者-呼吸机评估中计算静态顺应性和驱动压。

结果

插管前无创性呼吸支持的天数与顺应性和驱动压变差相关,但没有调节任何轨迹。COVID-19 阳性患者的顺应性每例呼吸机评估增加 0.08 单位,但无统计学意义( =.24),而 COVID-19 阴性患者(培养阳性或阴性)的顺应性均有统计学显著改善(分别为 0.12 和 0.18;均<.05);驱动压也观察到类似但相反的模式。

结论

与非 COVID-19 ARDS 相比,COVID-19 ARDS 与更险恶的轨迹相关,静态顺应性或驱动压无改善。虽然插管前无创性呼吸支持的天数与死亡率之间没有关联,但它的使用与整体顺应性和驱动压较差有关。